AMENDED & RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 14th, 2007 • VioQuest Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Amended & Restated Exclusive License Agreement (hereinafter referred to as this “Agreement”), effective as of December 29, 2006 (the “Effective Date”), is entered into by and between Asymmetric Therapeutics, LLC, (“Licensor”) a limited liability company duly organized under the laws of the State of Delaware and having a place of business at 141 Main Street, Unadilla, New York 13849, Onc Res, Inc., a corporation duly incorporated under the laws of the State of New York (“Onc Res”) and having a place of business at 141 Main Street, Unadilla, New York 13849, Fiordland Pharmaceuticals, Inc., a corporation duly organized and existing under the laws of the State of Delaware and having a place of business at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and, for purposes of certain provisions hereof, Stason Pharmaceuticals, Inc., a corporation duly incorporated under the laws the State of California (“Stason”) and having a place of business at 11 Morgan, Irvine, Cal
